Intellectual Property India Publishes Patent Application for In-Situ Gel Formulation For The Management Of Insomnia With Prolonged Drug Release And Enhanced Bioavailabilty

MUMBAI, India, June 30 -- Intellectual Property India has published a patent application (202641072929 A) filed by Saveetha Institute Of Medical And Technical Sciences on June 12, 2026, for In-Situ Gel Formulation For The Management Of Insomnia With Prolonged Drug Release And Enhanced Bioavailabilty.

Inventors include Dr. R. Thirumalaikumaran; Sahanaa Viayabaskaran; Subathra Sundar; Dhaniyalakshmi Manigandan; and Deepak Nallaswamy Veeraiyan.

The application for the patent was published on June 26, 2026, under issue no. 26/2026.

Abstract: Modern-day stress is the leading reason for the growing incidence of insomnia around the globe. Existing sleep treatments, especially for patients with diabetes, may lead to dependence and several other ...